Company / Free Cash Flow per Share
10x Genomics, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.06
FY2025
5-year range
-$1.47 / $1.06
FY2021-FY2025
Trend
+2311.8%
vs FY2024
Sector context
#86 of 142
Health Care
What the data says
Free Cash Flow per Share changed +2312% YoY in FY2025, a notable deviation from the 8-year average annual change of +227%.
Based on SEC 10-K filings.
1.06 in FY2025.
Improved from $-0.55 to $1.06 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 142 in Health CareTop 61% of 142This company $1.06 Sector average $5.16
▼
-79.4% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 2311.8% year-over-year.
- Ranks #86 out of 142 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.06 | +2311.8% |
| FY2024 | -$0.05 | +91.3% |
| FY2023 | -$0.55 | +62.3% |
| FY2022 | -$1.47 | -29.9% |
| FY2021 | -$1.13 | +57.3% |
| FY2020 | -$2.65 | -374.2% |
| FY2019 | -$0.56 | +91.0% |
| FY2018 | -$6.17 | -395.0% |
| FY2017 | -$1.25 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026